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Abstract 
It appears to be a time of turbulence within the global drug policy landscape. The historically 
dominant model of drug prohibition endures, yet a number of alternative models of 
legalisation, decriminalisation and regulation are emerging across the world. Whilst critics 
have asserted that prohibition and the ensuing ‘war on drugs’ lack both an evidence base 
and legitimacy, reformers are embracing these alternatives as indicators of progressive 
change. This paper, however, argues that such reforms adhere to the same arbitrary 
notions, moral dogma and fallacious evidence base as their predecessor. As such they 
represent the ‘metamorphosis of prohibition’, whereby the structure of drug policy changes, 
yet the underpinning principles remain unchanged. Consequentially, these reforms should 
not be considered ‘progressive’ as they risk further consolidating the underlying 
inconsistencies and contradictions that have formed the basis of drug prohibition.  
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Introduction 
There is a transformative change in the global drugs policy landscape with significant 
adjustments to the historically dominant model of prohibition emerging, leading some 
commentators to suggest a ‘quiet revolution’ is taking place (Rosmarin and Eastwood, 
2011). Policies of drug decriminalisation, legalisation and regulation are materialising in a 
number of jurisdictions around the world, a phenomena welcomed by critics of prohibition 
who have long exposed its lack of evidence base (Boland, 2008), efficacy (GCDP, 2014) and 
legitimacy (Pryce, 2012). Whilst a number of these reforms have been posited as 
‘progressive’ (Transform, 2014), this paper argues that they represent the ‘metamorphosis 
of prohibition’ whereby the face of drug policy changes yet the fundamental principles 
remain unaffected. Inadvertently, this reform ‘revolution’, camouflages the underlying 
contradictions that have lain at the heart of global drug policy since they were enshrined in 
the United Nations (UN) Single Convention on Narcotic Drugs in 1961. 
This paper, therefore, seeks to expose how the fundamental inconsistencies of drug 
prohibition continue to be accommodated in policy reform. It will do so by exploring two 
interlinking issues; firstly it will identify the untenable flawed assumptions underpinning 
drug law enforcement and prohibition. It will contend that certain ‘fallacies’ used to 
legitimise drug prohibition lack an evidence base, and instead draw upon myth and a 
reductionist discourse that obscures nuanced drug policy debate. These fallacies arbitrarily 
frame particular substances as ‘drugs’ and skew the risks of ‘drug use’ by focussing almost 
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exclusively on specific types of use and users, and concentrating attention upon associated 
negative outcomes. This process allows certain substances to attain an unwarranted 
position of privilege whilst others are prohibited, creating a ‘drug apartheid’ – a deeply 
divisive system of segregation and punishment determined by the substance used.  
Secondly, the paper will reflect on how the changing global policy landscape and ad hoc 
reform strategies are essentially rooted within a prohibitionist mind-set resulting in the 
‘metamorphosis of prohibition’ – whereby a raft of reforms give the impression of 
progressive drug policy evolution, yet actually mask a continuation of the arbitrary and 
contradictory processes that underpin contemporary drug policy. Consequentially the paper 
concludes that given the paucity of rationale, evidence and lack of scientific analysis 
upholding both prohibition and the current wave of alternative strategies, that the repeal of 
drug laws rather than superficial policy reform is necessary. 
The paper will utilise the United Kingdom as a lens through which to scrutinise drug 
prohibition whilst drawing on comparative reform policies from across the globe to illustrate 
how fallacy continues to inform, motivate and legitimise drug policy change. This 
examination of drug policy, critiquing the fundamental evidence base upholding both drug 
prohibition and drug reform has international significance.  
 
A changing landscape? 
The 1961 UN Single Convention on Narcotic Drugs listed those ‘narcotic’ substances that 
required strict legal controls. In doing so it represented a significant shift away from drug 
regulation towards a more prohibitive approach (Bewley-Taylor and Jelsma, 2012), 
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providing the legislative bedrock for contemporary global drug controli. For almost five 
decades relatively little changed, however, recent years have witnessed a wave of 
alternative drug policies, including models of decriminalisation (e.g. Portugal, Spain, 
Jamaica), legalisation (e.g. Uruguay, US States) and regulation (e.g. New Zealand). Despite 
these adjustments, no single jurisdiction has completely decoupled itself from the 
prohibition modelii. Whilst these reforms indicate a growing turbulence and diversification 
within the drug prohibition landscape, it is questionable whether this amounts to a 
‘revolution’. Some reform advocates have argued that incremental drug policy change 
represents positive progress (Rolles and Kushlick, 2014), however, such strategies risk 
strengthening rather than challenging the fundamental flawed principles on which 
prohibition is built. We argue these ‘reforms’ fail to address the drug apartheid and instead 
perpetuate the arbitrary distinctions concerning ‘drugs’ that privilege some substances as 
legal while prohibiting others.  
 
The 1961 Convention asserts that ‘narcotic drugs’ have no place in society and must be 
restricted to medical and scientific purposes, but the Convention, offers no scientific 
definition to determine a ‘narcotic’ drugiii. Narcotics or controlled drugs as they are referred 
to, are simply those substances listed in the UN document, a list that reflects social and 
cultural practices of the mid-20th century, rather than any pharmacological or scientific 
evidence (Bancroft, 2009), and despite new knowledge this arbitrary categorisation of 
substances prevails.  Under the UK Misuse of Drugs Act 1971, strict rules govern storage, 
cultivation, possession and supply of these controlled substances, and any breach attracts 
severe penalties. The UK Drug Strategy (Home Office, 2010: 9) emphasises the danger posed 
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by narcotics: ‘people should not start taking drugs and those who do should stop’, however, 
the government warning against ‘drugs’, excludes state approved drugs such as caffeine, 
alcohol, tobacco and sugars. Further, the Misuse Of Drugs Act 1971 with its ABC 
classification system sanctions severe punishments for anyone possessing or supplying 
‘drugs’, vehemently enforced by a concerted national and international collaboration 
involving police, armed forces, border control officials, security and secret services. In 
addition, rapidly expanding civil enforcement measures include ‘drug’ testing by employers, 
schools, colleges and welfare agencies (Buchanan, 2010), while government bodies, non-
government organisations and private companies exclude known ‘drug’ users from 
education, employment, travel, housing, medical provision, financial credit and/or 
insurance. 
The rationale for this relentless punitive approach led by the UN, may appear to have some 
validity given the perceived threat posed by ‘drugs’. The association between ‘drug’ use and 
crime in the UK is well documented and commonly asserted (Boreham et al., 2006; Budd et 
al., 2005), and the detrimental impact of drug use upon individuals, families and 
communities is frequently cited in UK governmental documentation (Home Office, 2008, 
2010). Whilst this apparent body of evidence has been contested as methodologically 
flawed (Stevens, 2007) and limited in scope (Moore, 2008), it nonetheless presents a 
persistent and forceful rhetoric to bolster prohibition.  
 
The social construction of ‘drugs’. 
6 
 
The omission of legal drugs from drug policy debate, portrayed as ‘non-drugs’, has created a 
bifurcation, reinforced by the social construction of narcotics or dangerous ‘drugs’ 
(Buchanan, 2006). Dangerous drugs are perceived as those substances listed under the 
Misuse of Drugs Act 1971, a continually expanding list, with Mephedrone, BZP and Khat 
more recent additions. Once included in the Act substances become ‘controlled’ dangerous 
drugs, while legally promoted counterparts fly under the ‘drug’ radar. Scientists, academics 
and experts in the field have long questioned the rationale of this drug bifurcation, 
highlighting the contradictions, inconsistencies and hypocrisy (GCDP, 2014) and the 
misleading nature of the Misuse of Drugs Act 1971 as a guide to potential risk (Rolles and 
Measham, 2011). Indeed, Nutt et al.’s (2010) research illustrates that legal-illegal 
distinctions are not based on scientific principles of harm, and that legally approved 
substances such as alcohol and tobacco, present far greater potential for harm than many 
Class A drugs. 
In recent years a number of jurisdictions (e.g. Uruguay, certain US states) have amended 
their drug laws to permit the use of cannabis, and proponents for drug reform appear to 
assume that cannabis is the obvious drug to legalise ‘first’, but the reasons for this seem no 
different to the arbitrary classifications in the 1961 UN Single Convention that prohibited 
substances used by a minority of ‘others’ whilst privileging those that were popular in the 
western world (Hari, 2015). The justification to privilege cannabis rather than substances 
such as ecstasy, LSD and psilocybin mushrooms which are relatively less harmful (Nutt et al., 
2010) is a populist driven decision, rather than one rooted in science. The lack of scientific 
evidence driving the legalisation of cannabis indicates the capricious nature of drug law 
reform and perpetuates a drug apartheid based on privilege and populism rather than 
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rationale and evidence. Given the dearth of scientific rationale upholding drug laws it may 
seem difficult to comprehend how policies based on such arbitrary notions attain and 
maintain legitimacy, however, an examination of the reductionist discourse surrounding the 
social construction of ‘drugs’ can help our understanding.  
 
Deconstructing drugs: A reductionist discourse 
Since the Misuse of Drugs Act 1971 there has been an intensive multi-disciplinary effort 
across the UK to remove banned substances from circulation and protect communities from 
the purported dangers (Home Office, 1998, 2008, 2010). This campaign is part of a global 
effort impelled by the UN to ensure zero-tolerance towards narcotics. In 2012, when 
confronted by a growing number of countries seeking to accommodate certain narcotic 
drugs (particularly cannabis), Raymond Yans, President of the UN International Narcotics 
Control Board (INCB), urged countries to stand firm:  
“governments must continue to strengthen their efforts in the licit control of 
narcotic drugs and psychotropic substances…I cannot over-emphasize the 
importance of international cooperation and shared responsibility in facing all facets 
of the global drug problem” (UNIS, 2012: 1). 
Those substances labelled as ‘drugs’ are seen to pose a global threat requiring international 
cooperation and tough action. In response to the legalisation of cannabis in certain 
jurisdictions, the INCB President robustly asserts "such initiatives, if pursued, would pose a 
grave danger to public health and well-being, the very things the States, in designing the 
conventions, intended to protect” (INCB, 2014: v). Furthermore, Yury Fedotov Executive 
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Director of the UN Office on Drugs and Crime (UNODC) called for greater international 
resolve: “many countries around the world are suffering…we must also ask ourselves tough 
questions about whether we have managed to reduce the global drug threat.…if we are 
really determined to confront illicit drugs, we must move with more determination” 
(UNODC, 2013). In the context of drug policy liberalisation, the UN seeks greater 
commitment for tough enforcement and prohibition. 
The UK Home Office (2014a, 2014b) recently underlined its full support of prohibition when 
it published simultaneous reports, one considering international comparative drug policies 
while the other explored the management of Novel Psychoactive Substances (NPS) – the 
former resulted in UK Prime Minister David Cameron declaring ‘the evidence is, what we’re 
doing [prohibition] is working’, emphasising that reform is not on the political agenda, whilst 
the latter report extended prohibition by proposing a blanket ban on all NPSiv. It seems 
curious that during a period of apparent reform, the UK is set to join Eire and New Zealand 
by banning all NPS, further entrenching the drug apartheid. The UK government’s 
commitment to drug prohibition and refusal to consider any ‘liberalisation of drug laws’ 
(Home Office, 2010: 2) remains resolute with the Prime Minister emphasising that ‘I don’t 
believe in decriminalising drugs that are illegal today …I’m a parent with three children – I 
don’t want to send out a message that somehow taking these drugs is okay and safe 
because, frankly, it isn’t’ (cited in Morris and Cooper, 2014). 
While some writers have contributed to an informed nuanced narrative of illicit drug taking 
(Aldridge et al., 2011; Seddon, 2010; Stevens, 2011), political rhetoric and UK media 
coverage of drug policy delivers a strong ideological crusade against what it calls ‘drugs’,  
focusing almost exclusively upon the damaging consequences arising from a minority of 
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problematic drug users, and conveniently conflating drug use with drug misuse, resulting in 
a negative portrayal and stereotype of the ‘drug user’ (UKDPC, 2012). The dominant 
prohibitionist discourse on ‘drugs’ then takes place within a framework preoccupied by 
compulsion, pain and pathology (O’Malley and Valverde, 2004), in which drug use is 
presented as an activity undertaken by a small group of risk bearing ‘outsiders’, that 
inevitably leads to desperation and addiction (Taylor, 2008).  
Media representations frame ‘drugs’ as causing; petty crime (Salkeld, 2009); serious crime 
(Stretch, 2014); organised crime (Daily Mail, 2013); mental illness (Byrne, 2011); psychosis 
(Bloom, 2014); and physical and moral decay (Ayres and Jewkes, 2012) and wrongly 
presents drug use as a significant causal factor in a range of societal problems including: car 
accidents (Romano et al., 2014); workplace accidents (Price, 2014); disease (Ceste, 2010); 
and child abuse (Ryder and Brisgone, 2013), and so prohibition is legitimised by the 
construction of ‘drugs’ as unsafe and extremely harmful. Whereas in contrast to the 
rhetoric, the reality is that the majority of illegal drug use is non-problematic, most 
commonly associated with leisure, pleasure and desired outcomes (Hunt et al., 2010) and 
rarely does drug use lead to addiction (Cloud and Granfield, 2001) or require treatment 
(Siliquini et al., 2005). Importantly, given the lack of empirical evidence to uphold 
prohibition the rhetoric could be more accurately described as fallacies that have their roots 
in the social and political construction of ‘drugs’ and a reductionist analysis (Ayres and 
Jewkes, 2012). Crucially, this discourse employs and indeed perpetuates these myths as the 
ongoing evidence base to provide legitimacy for prohibition. 
By distorting the social reality surrounding drugs and drug users, the media provides the 
‘reality effect’ of ideology (Hall, 1982). In symbolising normality (Cohen, 1971) the media 
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constructed matrix of ‘drugs=danger=death’ provokes social conformity by frequent graphic 
illustrations of the negative consequences associated with the use of these prohibited 
drugs. By engendering fear and highlighting extreme case stories, the media create a hyper-
reality constructing a ‘simulacrum’ of drug use (Baudrillard, 1994), what Baudrillard aptly 
refers to as a process ‘of proving the real by the imaginary; proving truth by scandal’ (1983: 
36). Since the creation of the 1961 UN Single Convention this simulacrum of ‘drug use’ has 
become more real and influential in shaping our perceptions, knowledge and policies on 
drugs, than rationality, science and evidence, and indeed worryingly, such distortions have 
been accepted and adopted by drug reformers (Reynolds, 2015).  
Perpetuating these fallacies within a reductionist discourse has far reaching consequences. 
Firstly, it continues the ‘routinisation of caricature’ (Boyd, 2002) whereby all use of illicit 
substances becomes conflated with problematic drug use. Secondly, the enjoyment, 
benefits and pleasures derived from illicit drug use are inadequately researched, 
acknowledged and discussed (Moore, 2008). Thirdly, drugs policy becomes impervious to 
scientific evidence and instead takes its lead from political ideology (Boland, 2008). Fourthly, 
policy responses tend to focus almost exclusively upon problematic use and fail to 
comprehend the policy needs of recreational drug users (Taylor, 2011). The current raft of 
policy ‘reforms’, which tweak and utilise the existing drug war paradigm have done little to 
address these fundamental issues that sustain the drug apartheid.  
 
Reforming Prohibition? 
In 2012 when Nick Clegg (UK Deputy Prime Minister) advocated drug policy reform it was 
perhaps indicative that he simultaneously maintained his commitment to reductionist drug 
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war propaganda, arguing ‘I’m anti-drugs, it’s for that reason that I’m pro-reform’ [our 
emphasis]. The underlying motivation for reform here is rooted in moral bias rather than 
science and reasoning.  
 
A key reformist argument is to cite countries like The Netherlands and Portugal who have 
introduced elements of decriminalisation, and claim they are successful precisely because 
decriminalisation has had little impact on rates of drug use (Rosmarin and Eastwood, 2011: 
42). Portugal for example, has been heralded as a progressive reform model for drug policy 
since it decriminalised personal possession of all drugs in 2001 with levels of drug use 
remaining stable and comparable to neighbouring countries (Hughes and Stevens, 2010). 
Such indicators of effectiveness, however, further reinforce the ‘anti-drugs’ prohibitionist 
discourse that sees drug use as undesirable and problematic. In addition, Portugal continues 
to support prohibition with 15% of personal possession rulings in 2012 resulting in a 
punitive outcome; Portugal continues to criminalise individuals caught in possession of 
amounts above the decriminalised threshold limitv and continues to imprison people for 
drug defined crimes with 21% of the Portuguese prison population incarcerated under drug 
laws (RNFP, 2013).  
 
Within these ‘liberal’ reforms the central tenets of prohibition remain – the ability to 
criminalise and severely punish users and suppliers of certain substances. Such processes 
have been historically steeped in prejudice, resulting in a racially motivated ‘war on drugs’ 
(Boyd, 2002) and despite reform, discrimination and inequality endures. For example, black 
people continue to be arrested for possession of cannabis in Colorado at exactly the same 
disproportionate rate (2.4 times more than white people) as they were prior to cannabis 
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legalisation. Similarly, whilst black people comprise around 3.9% of the population in 
Colorado, they accounted for 18.1% of arrests for cannabis distribution in 2014 (Drug Policy 
Alliance, 2015a). 
 
Whilst decriminalisation in Portugal has resulted in some promising developments in 
reducing drug related harm, such as: a reduction in drug related deaths; a reduction in 
infectious diseases; an increase in drug treatment uptake; and a reduction in the level of 
problematic drug users (Hughes and Stevens, 2010), these outcomes emerge through the 
lens of prohibition and the preoccupation with negative associations with drug taking such 
as death, disease and addiction. Whereas, the vast majority of illicit drug users in Portugal 
(as elsewhere around the globe) are recreational drug users, who do not die, contract 
diseases, require drug treatment or become ‘problematic users’; yet their rights and needs 
seem to go unnoticed. Similarly, in respect of cannabis legalisation in Colorado reformers 
cite evidence of: arrests and judicial savings; decrease in crime rates; decrease in traffic 
fatalities; and increased tax revenue and economic benefits (Drug Policy Alliance, 2015b), 
measurements which once again have their roots in the prohibitionist reductionist 
discourse. 
Prohibition has privileged and promoted particular drugs while the use of other substances 
has been outlawed and punished. The current reform momentum towards legalising or 
decriminalising particular substances (such as cannabis) so they can become ‘privileged’, 
reinforces the existing drug apartheid and fails to fundamentally address the contradictions 
and lack of evidence base upon which prohibition is premised. Such reforms amount to little 
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more than a ‘metamorphosis of prohibition’, since they fail to address the fundamental 
fallacies underpinning the drug apartheid. 
 
Reconstructing Drugs: The five fallacies of drug prohibition 
1. There is a scientific reason why some substances are categorised as ‘drugs’. 
A war needs an enemy and successive governments have rallied a war against ‘drugs’, but 
there is no rationale for the substances we have come to regard as drugs. If we assume a 
drug is a psychoactive substance that alters our mood state (Nutt, 2012), then we have to 
include alcohol, tobacco and caffeine along with a wide range of other substances currently 
categorised as: herbs (e.g. nutmeg); medicines (e.g. codeine); foods (e.g. sugar); and legal 
highs (e.g. Spice).  Angus Bancroft exposing the ‘drug’ fallacy explains: ‘there are no 
pharmacological categories of ‘illicit drugs’, ‘licit drugs’ and ‘medications’. They are social 
categories constructed because as a political community we have come to treat some 
substances differently from others, depending on who uses them, how and for what’ (2009: 
8). If instead we assumed that prohibition was concerned with outlawing the most 
‘dangerous drugs’, then according to the evidence a range of illegal substances such as khat, 
LSD, psilocybin mushrooms and ecstasy would become legal; while currently legal 
substances such as alcohol, tobacco and arguably sugars would become prohibited. 
Any scientific examination of ‘drugs’ renders the present classification of illicit drugs as 
illogical and the present cultural promotion of legal substances as misguided. The idea 
promoted by the UN of being against ‘drugs’ and seeking a ‘drug free world’, is not only 
untenable and unthinkable, it is undesirable. Therefore, the notion of Nixon’s ‘war on drugs’ 
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is a contradiction; there has never been a war on drugs, only a war on particular drugs, a 
war seriously lacking coherence, without a rational basis to support it.  More accurately it is 
a ‘war between drugs’ a system of drug apartheid that has privileged the use of certain 
substances and outlawed the use of other substances, a corrupt system that has much to do 
with who uses the drugs and little to do with the risks posed by the drugs (Nadelmann, 
2014). 
In the US, while several states have legalised cannabis, they continue to have a zero 
tolerance policy towards other less harmful substances (Nutt et al. 2010). Such reforms fail 
to address the fundamental flaws of prohibition and instead support the myth of ‘drugs’ by 
reinforcing the drug apartheid by inviting cannabis to enjoy the privilege afforded to alcohol, 
tobacco and caffeine. This is a move that potentially obfuscates important underlying drug 
policy issues and risks dividing the drug reform momentum by appeasing a large group of 
previously criminalised cannabis users. Worryingly, the key motivation for privileging 
cannabis appears to be its popularity and income generation potential.  
Conversely, whilst drug laws around cannabis are relaxed in various US states, recent 
international responses to Novel Psychoactive Substances (NPS) suggest a strengthening 
grip of prohibition (Stevens and Measham, 2013) by extending the scope of substances 
classified as ‘drugs’. One of the first countries to respond was New Zealand with the 
Psychoactive Substance Act 2013 which was hailed by reformers as showcasing ‘world 
leading’ drug reform (McCullough et al., 2013), because it included a theoretical possibility 
of drug regulation. However, the Act also provides new powers to prohibit and punish 
personal possession of every NPS unless state approved (s.71), impose two years prison for 
anyone supplying an unapproved NPS (s.70), and provides the police with new powers to 
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enter premises without a warrant (s.77). While the UK Misuse of Drugs Act 1971 prohibits 
only those substances listed, the New Zealand Psychoactive Substance Act 2013 reverses 
this process prohibiting every NPS unless state approved (no substances have currently 
been approved at the time of writing). The Psychoactive Substance Act strengthens the 
illegal-legal bifurcation of drugs, extends state control and widens the net of prohibition, yet 
reform experts promote it as ‘a sensible and pragmatic approach’ (Bassil, 2015). 
 
2. Prohibiting drugs protects society.  
The arbitrary Misuse of Drugs Act 1971 classification of drugs posits that society requires 
protection from particular substances through the criminal justice system whilst 
simultaneously indicating that other legal substances can be managed via legal regulation, 
this taxonomy wrongly assumes prohibition is able to reduce supply and demand and 
protect society from harm. Prohibition not only fails to protect, it actually creates more 
harm by placing users at risk of a drug conviction that can have serious life-long 
consequences detrimentally impacting upon education, employment, housing, travel and 
relationships – indeed criminalisation itself arguably poses far greater harm to a person’s 
future well-being than the drugs themselves (Buchanan, 2015; Lenton et al., 2000).  
Evidence suggests that neither tough drug policy, nor liberal drug policy, have much impact 
upon levels of drug use (Hughes and Stevens, 2010), but prohibition places responsibility for 
the content, strength and purity of drugs to underground organisations who, whilst 
motivated by the same profit orientated goals as licit drug manufacturers, are unregulated 
and unable to operate openly. This forces illicit users to engage in criminal networks to 
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purchase and use unknown substances while having no legal recourse when issues arise. 
The risks of drug-related disease, overdose and death linked with drug use are largely 
caused by prohibition (Buchanan, 2009). Unless prohibition is abolished and all drugs are 
regulated and legal to possess, ‘reforms’ will continue to punish users of unapproved and/or 
outlawed drugs, driving them underground and significantly increasing harms. 
 
3. Drug use causes crime and social problems. 
Drug policy has been premised on a contested causal relationship between drug use and 
crime (Home Office, 1998, 2008, 2010), ‘evidenced’ via research undertaken with 
unrepresentative samples of drug users (Boreham et al., 2006; Budd et al., 2005) which fails 
to acknowledge the complex and multifaceted nature of drug use (Stevens, 2011), or 
consider those users not in contact with criminal justice or treatment agencies (Manzoni, 
2006; McSweeney and Turnbull, 2007). 
Closer examination suggests the drug-crime connection is tenuous, while the majority of 
arrestees in the UK use drugs (59%), they are not problematic usersvi and report little or no 
causal connection between their drug use and offending (UKDPC, 2008). Contrary to 
prohibitionist driven ideology problematic drug users represent only 22% of drug using 
arrestees, and although two thirds of this group (64%) report committing crime to acquire 
drugs, they represent a small minority of the drug using offender population (UKDPC, 2008). 
The popular stereotype of the drug-driven addict, however, continues to inform policy and 
exaggerate the extent of crime caused by drug dependence (Stevens, 2011).  
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There is however, a clear causal drug-crime connection established by the prohibition of 
substances under the Misuse of Drugs Act 1971  (Pedersen and Skardhamar, 2009), in which 
crime is not driven by any pharmacological impact of the drug, but fuelled by the process of 
tough law enforcement upon outlawed substances: ‘using drug-related crime as a 
justification for the war on drugs is unsustainable given the key role of enforcement in 
fuelling the illegal trade and related criminality’ (Rolles et al., 2012: 10). Prohibition 
amplifies the crime rate via the criminalisation of thousands of otherwise law abiding 
citizens and young people (Pedersen and Skardhamar, 2009). Further, the associated social 
problems of crime, violence and deviant behaviour linked with the ‘drug underworld’ have 
less to do with the drug and more to do with prohibition that spawns criminal activity and 
deviant sub-cultures. Research has shown that tough enforcement measures that disrupt 
and destabilize the illegal market, are strongly associated with increases in drug related 
violence (Werb et al., 2011) whilst simultaneously exacerbating the harms experienced by 
individual users and wider society (Kerr et al., 2005).  
Current reform models fail to address these issues but continue to: criminalise users of 
certain substances; arbitrarily distinguish so called ‘soft’ drugs from ‘hard’ drugs (those that 
are perceived to lead to crime and social problems); employ policies based on a contested 
drugs-crime causal relationship which attempts to coerce offenders who use illicit drugs into 
abstinence orientated treatment; use considerable financial resources recouped from 
justice savings/confiscation orders in the policing of drugs to further step up enforcement 
on drug production and supply, inadvertently fuelling further criminal activity, risk and 




4. Drug use has no place in civilised society. 
The 2014 Crime Survey for England and Wales (CSEW) suggests 2.7 million (8.2% of the 16-
59 year old population) have used illicit drugs in the past year alone, with 920,000 (2.8% of 
this population) defined as ‘frequent users’ (ONS, 2014) compared to an estimated 298,752 
‘problematic’ drug users (Hay et al., 2013). Clearly using illicit drugs is not uncommon, and 
problematic use is confined to a minority, despite this ‘drug use’ remains curiously framed 
as a deviant activity, undertaken by outsiders, resulting in undesirable life threatening 
outcomes (Taylor, 2008).  
The use of drugs for pleasure or recreation has occurred throughout history (Buchanan, 
2009) and will continue to do so. Drug use per se is not immoral, but the use of particular 
drugs (those made illegal in the UK Misuse of Drugs Act 1971) has been socially constructed 
as dangerous, immoral and deviant while the use of other substances is promoted and 
culturally embedded (Measham and Brain, 2005) - this position is contradictory, inconsistent 
and unsustainable.   
Scientifically there is no pharmacological or rational basis to distinguish between licit and 
illicit substances. If recreational drugs have no place in society then the logical conclusion is 
there is no place for tea, coffee, fizzy drinks or hot chocolate that all contain the stimulant 
drug caffeine or the addictive substance sugar, and no place for the depressant drug 
alcohol. This would be an untenable position to defend and impossible to enforce. Currently 
legal substances are used daily and valued for: providing energy; making us more alert; 
helping us relax; become more sociable; chill out; sleep; and have fun; unsurprisingly illicit 
drugs are used as part of everyday life for the very same purposes and could also be 
beneficial to that individual’s wellbeing and health (Boys et al., 2001).  
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This skewed perception embedded within the drug apartheid, of overlooking the harms 
posed by legally approved substances and denying the normalisation and benefits of 
recreational illicit drugs in society obscures that: drugs can be acquired easily and are readily 
available (Aldridge et al., 2011); drug use permeates all sections of society (Aldridge, 2008); 
most people use drugs responsibly, sensibly and recreationally (Measham et al., 2001); most 
drug taking is controlled rather than chaotic (Shewan and Dalgarno, 2005); most drug users 
enjoy and take pleasure from their use (Hunt et al., 2010); most drug users exercise agency 
and choose to use drugs rather than finding themselves propelled by a series of external 
pressures and/or negative life experiences (Aldridge et al., 2011); and most drug use does 
not result in drug-related crime (Stevens, 2011). Within a stifled prohibitionist drug 
discourse such statements, despite being evidenced, might be perceived as provocative, 
dangerous or even promoting drugs by ‘sending out the wrong message’. Interestingly, if re-
read in relation to caffeine and alcohol such statements suddenly become entirely 
reasonable. The social construction of ‘drugs’ provides a distorted lens through which licit 
and illicit drug use is seen, where reason, logic and science become clouded by ideology, 
dogma and intolerance. A process that reflects the wider political climate, which elevates 
feeling and prejudice above reason and evidence (Cohen, 2013). 
Policies such as the New Zealand Psychoactive Substances Act 2013, represent little more 
than a metamorphosis of prohibition as they extend state power to determine and sanction 
the personal use of certain drugs while outlawing and punishing the use of other 
substances. Such laws fail to recognise that it is drug prohibition rather than substance use 
itself that causes most harm. With a lack of evidence that drug use per se causes significant 
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harm, the role of law enforcement over what a person can and cannot consume becomes 
very questionable. 
 
5. Continued drug use inevitably leads to addiction. 
Use of any banned drug is portrayed as dangerous, and little distinction is made between 
use and addiction. Similar to people who use alcohol, illicit drug users are generally sensible, 
recreational users, and no more likely to be irresponsible or become ‘addicts’ than regular 
wine, beer or spirit drinkers are likely to become ‘alcoholics’. There is no inevitable 
progression that regular drug use is likely to lead to drug addiction (Hart, 2013). The idea 
that a ‘gateway’ drug leads to escalated drug use and/or addiction is unfounded (ACMD, 
2008), and while some substances are for some people more addictive than others, there is 
no substance that once taken turns people into ‘addicts’ (Hart, 2013).   
It is widely assumed that the traumas associated with chronic dependent use of drugs are a 
direct consequence of addiction to illicit substances; however, closer examination indicates 
a host of other, more deep-rooted socio-economic issues, disadvantages and personal 
traumas often precede addiction (Stevens, 2011). It may be politically expedient to present 
lives that have been damaged by deindustrialisation, poverty, unemployment, exclusion, 
abuse and/or trauma as caused by ‘drugs’, however, chronic problematic drug use is more 
often a symptom of wider underlying issues, not the causal factor (Buchanan 2006; 
MacGregor and Thickett, 2011). In terms of problematic drug use, the set (the person) and 
setting (the environment) are more influential risk factors than the substance (Zinberg, 
1984). For example, when Switzerland prescribed clean injectable heroin maintenance, long 
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term problematic users were able to move away from the damaging illegal environment and 
pattern of life and were able to engage in productive and healthier lifestyles - despite their 
ongoing use and physical dependence upon pharmaceutical heroin (Ceste, 2010). 
Reformers seeking incremental change may be afraid to argue for the legalisation of all 
drugs, but the numerous successful Heroin Assisted Treatment programmes, such as in 
Switzerland, provide a robust evidence base (Strang et al., 2012) that drugs, even injected 
heroin, do not inherently of themselves lead to problematic drug use, and legalising all 
drugs would remove the associated harms caused through: cutting drugs with toxic agents; 
uncertainty of strength and purity; and the acquisition through the criminal underworld. 
 
Conclusion 
The UK government claims it is ‘committed to an evidence-based approach, high quality 
scientific advice in this complex field is therefore of the utmost importance’ (Home Office, 
2010: 9), however, this article has demonstrated there is a paucity of evidence to support 
this claim. Drug policy nevertheless, seeks to vindicate itself by continuing to assert that 
illicit drugs cause a wide range of harms, and that drug prohibition protects society from 
these harms, but to the contrary, the evidence indicates the present drug policy is causing 
more harm and offering little or no benefits to either users or non-users. Drug policy 
premised on media driven myth, flawed assumptions and political populism lacks credibility 
and legitimacy. The UK drug policy imbues prohibited drugs with innate powers to cause 
crime, poverty, family and community breakdown, disease and even death, and drugs have 
become society’s scapegoat (Szasz, 2003). This demonization of drugs conveniently detracts 
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from the more complex personal, social and structural drivers of addiction, such as poverty 
and social exclusion (MacGregor and Thickett, 2011); whilst it also avoids addressing the 
hypocrisy inherent in the bifurcation of substances (Buchanan, 2009). 
This paper contends recent shifts towards selective regulation, decriminalisation or 
legalisation fail to tackle fundamental drug war fallacies, and perpetuate a discourse rooted 
in prohibition rather than scientific evidence and reason. Selectively inviting particular drugs 
to join alcohol, caffeine and tobacco as commercial products is a dubious and uncertain 
pathway towards dismantling prohibition. Reform advocates may argue these alternative 
drug policies represent a progressive incremental movement – but we contend that these 
amendments symbolise the ‘metamorphosis of prohibition’, and are rooted in the drug 
policy malaise. Indeed, tweaking the flawed model risks obfuscating the fundamental 
contradictions and hypocrisy at the heart of prohibition and the 1961 UN Single Convention.  
We would argue that the 1961 Convention was not a mistake; it was a deliberate strategy to 
protect the privileged position of the preferred drugs, its users and the associated industries 
dominating the western market in the 1950/60s. Prohibition created the ’drug apartheid’ a 
brutal system of inclusion and exclusion, rooted in the politics and culture of maintaining 
power and privilege. The contradictions between legal and illegal drugs and the arbitrary 
classification of drugs in the UK Misuse of Drugs Act 1971 suggest this law is no longer fit for 
purpose and should be repealed not reformed. There is a need to challenge the social 
construction of ‘drugs’ and the ‘drug user’, a need to develop a new approach that is rooted 
in human rights, health and social care and not prohibition, criminalisation and punishment. 
Drug reform must engage in the difficult and complex process of exploring how best to 
legalise and regulate all psychoactive substances that are currently legal and illegal, to 
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develop a drug policy that seeks to embrace and accommodate the use of all drugs in 
society rather than prevent, deny or privilege particular drug use. Drug reformers who see 
incremental adaptations to existing drug policy as stepping stones towards ending 
prohibition should at the very least be clear about the transitory nature of such ‘reforms’, 
and vocal and explicit about long term goals. This is however, a risky strategy that too often 
involves compromising key principles and confusing important issues to achieve short-term 
gains. Each incremental step must be part of dismantling the drug apartheid; it cannot be 
seen to be colluding with or supporting ongoing systemic misinformation, unsound policies 
and practices that are rooted in prohibition. 
The current raft of reforms fail to expose and challenge the very principles that underpin 
prohibition; instead they perpetuate the flawed discourse upholding it. The drug apartheid 
is a deeply divisive and damaging system that cannot be adapted, but must be dismantled. 
Abolition inevitably requires a process of transition, it could begin with the decriminalisation 
of all possession, cultivation and production for personal use – while acknowledging and 
planning a model of regulation to address the ongoing harm caused by the perpetuation of 
wider prohibition and the continued criminalisation of those involved in manufacture and 
supply. Unless a mature, scientific and evidence-based approach to drug policy reform is 
adopted that clearly starts to expose, challenge and dismantle the very foundations of the 
drug apartheid any new regulatory framework or so called reform is arguably little more 
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i Although the Single Convention on Narcotic Drugs consolidated and reinforced international drug prohibition, 
this was initially established in 1909-1912 with the Shanghai Opium Commission (1909) and the subsequent 
International Opium Convention of the Hague (1912). 
ii Despite the possession of certain substances or amounts of substances being 
decriminalised/legalised/regulated in certain jurisdictions there are no jurisdictions which have 
decriminalised/legalised/regulated the possession and/or supply of all previously illegal substances. As a 
consequence the prohibition of certain substances and the criminalisation of those who possess/supply these 
continues to be evident in every nation across the globe.  
iii The term ‘narcotic’ first appeared in the 1914 Harrison Act in the US to refer to opiates and cocaine. 
According to the World Health Organisation (1994: 47) ‘narcotic’ refers to ‘a chemical agent that induces 
stupor, coma, or insensibility to pain’, which is why it was used as a catch all term for opiates and the 
anaesthetic cocaine in the Harrison Act. However, the 1961 Single Convention on Narcotic Drugs provides no 
scientific definition of narcotic and although medically the term still refers to opioids, in its legal context and 
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everyday use it has become an all-encompassing term for prohibited drugs regardless of their pharmacology 
and thus erroneous. Due to the imprecise nature of the word narcotic the 1961 Convention should provide a 
clear and exact definition since it is the foundation of all subsequent prohibitionist legislation, despite only 
initially referring to opiates and cocaine. 
iv The resulting Psychoactive Substances Bill proposes a blanket ban on all Novel Psychoactive Substances and 
at the time of writing is passing through the UK House of Commons on its journey towards becoming 
legislation. 
v Portuguese possession limits are based on average consumption over a ten day period i.e. 25g for cannabis, 
1g MDMA, 0.3g for cocaine, 1g of heroin. 
vi Defined here as those who use heroin and crack cocaine. 
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